Protalix BioTherapeutics, Inc. Underwriting Agreements
3 Contracts & Agreements
- Underwriting Agreement, dated February 11, 2021, between the Company and BofA Securities, Inc (Filed With SEC on February 16, 2021)
- Protalix BioTherapeutics, Inc. 4,500,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on February 16, 2012)
- Underwriting Agreement (Filed With SEC on October 25, 2007)